 |
 |
Steve I'm guessing it is but don't know for sure. Its difficult to believe there could be more than one DT. Ray Rayilyn Brown Past Director AZNPF Arizona Chapter National Parkinson Foundation -------------------------------------------------- From: "Steve Rack" <[log in to unmask]> Sent: Thursday, April 29, 2010 8:07 PM To: <[log in to unmask]> Subject: Re: Ceregene has Initiated a New Phase 1/2 Trial Of CERE-120 for Parkinso n 's Disease > Is this the Dennis Turner who went ahead with Dr. Levesque and injected > stem cells into his brain? > > >>from: PR Newswire press release >>April 28, 2010, 7:00 a.m. EDT · >>Ceregene has Initiated a New Phase 1/2 Trial Of CERE-120 for Parkinson's >>Disease"SAN DIEGO, April 28, 2010 /PRNewswire via COMTEX/ -- >>Ceregene, Inc., a biopharmaceutical company, announced today that >>enrollment is proceeding in a new Phase 1/2 clinical study evaluating >>CERE-120, a gene therapy product which delivers the neurotrophic factor >>neurturin, to dying neurons in Parkinson's disease patients. This new >>clinical study follows a completed Phase 2 trial and builds on experience >>gained in that trial, by enhancing the dosing regimen and optimizing the >>duration of patient follow up. >>The new study was initiated in the fourth quarter of 2009 and is >>proceeding as planned. The ongoing Phase 1/2 trial will enroll six >>patients with advanced Parkinson's disease. The first four patients have >>been treated safely and two additional patients will be treated over the >>next two months. This Phase 1 open label portion of the trial is being >>conducted by Drs. Mark Stacy and Dennis Turner at Duke University School >>of Medicine, Drs. Michele Tagliati and Ron Alterman at Mount Sinai Medical >>Center, New York, and Drs. Stewart Factor and Nicholas Boulis at Emory >>University Hospital. Ceregene expects to initiate the next phase of this >>trial (a sham-surgery-controlled, double-blind Phase 2 portion) beginning >>during the third quarter of this year. The Phase 2 portion will include 10 >>leading US neurological medical centers. " >>full article >>at:http://www.marketwatch.com/story/ceregene-has-initiated-a-new-phase-12-trial-of-cere-120-for-parkinsons-disease-2010-04-28?reflink=MW_news_stmp >> >> >> >>__._,_.___ >> >>__,_._,___ >> >>---------------------------------------------------------------------- >>To sign-off Parkinsn send a message to: >>mailto:[log in to unmask] >>In the body of the message put: signoff parkinsn > > > -- > Steve in VT > > ---------------------------------------------------------------------- > To sign-off Parkinsn send a message to: > mailto:[log in to unmask] > In the body of the message put: signoff parkinsn ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn